Alembic Pharmaceuticals gets FDA approval for Doryx Tablets generic
Alembic Pharmaceuticals has bagged final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Doxycycline Hyclate Delayed-Release Tablets USP in the strengths of 75 mg, 100 mg, 150 mg, and 200 mg. Doxycycline Hyclate Delayed-Release Tablets USP is Alembic Pharmaceuticals’ generic version of Doryx Tablets, 75 mg, […]